Max Robotics — Global Service Robot Directory + US Certification

About

John Waldron is a leading clinician-researcher in head and neck oncology, specializing in the intersection of transoral robotic surgery (TORS) and precision radiotherapy for oropharyngeal cancers. His work has fundamentally reshaped treatment paradigms for patients with carcinoma of unknown primary (CUP) of the neck—a challenging diagnosis where the primary tumor site is initially hidden. Waldron’s landmark 2016 study (30 citations) demonstrated that TORS-assisted lingual tonsillectomy dramatically improves identification of occult base-of-tongue tumors, enabling targeted rather than blanket pharyngeal radiation. Building on this, his phase 2 FIND trial (2022) and subsequent 2024 study (12 citations) pioneered a strategy of radiation volume de-intensification guided by TORS findings, showing that patients with p16-positive CUP can safely receive smaller, more focused radiotherapy fields. This approach spares healthy tissue, reducing debilitating long-term side effects like dysphagia and xerostomia while maintaining excellent oncologic control. With cumulative citations exceeding 46 across his core publications, Waldron’s work is widely adopted in multidisciplinary tumor boards and has influenced national treatment guidelines. He continues to lead prospective trials refining de-escalation protocols, making him a pivotal figure in the movement toward less toxic, more personalized head and neck cancer care.